Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hartmann

Showing results (561-570 of 626) with videos related to

Pageof 63
Sort By:
Angewandte Chemie (International Ed. in English)|November 11, 2021
Substrate-Inspired Fragment Merging and Growing Affords Efficacious LasB InhibitorsCansu Kaya, Isabell Walter, Samir Yahiaoui, et al.
International Journal of Molecular Medicine|July 13, 2000
Expression of genes involved with cell cycle control, cell growth and chromatin modification are altered in hepatoblastomasS G Gray, W Hartmann, T Eriksson, et al.
Journal of the American Chemical Society|September 21, 2012
Validation of PqsD as an anti-biofilm target in Pseudomonas aeruginosa by development of small-molecule inhibitorsMichael P Storz, Christine K Maurer, Christina Zimmer, et al.
Journal of Medicinal Chemistry|November 11, 2005
Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approachAndrea Cavalli, Alessandra Bisi, Carlo Bertucci, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 4, 2011
17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor developmentSandrine Marchais-Oberwinkler, Claudia Henn, Gabriele Möller, et al.
Klinische Padiatrie|December 1, 2007
Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastomaM A Grotzer, K von Hoff, A O von Bueren, et al.
Oncogene|March 6, 2007
SGNE1/7B2 is epigenetically altered and transcriptionally downregulated in human medulloblastomasA Waha, A Koch, W Hartmann, et al.
Bioorganic & Medicinal Chemistry|October 22, 2013
Trisubstituted and tetrasubstituted pyrazolines as a novel class of cell-growth inhibitors in tumor cells with wild type p53Mohammad Abdel-Halim, Adam B Keeton, Evrim Gurpinar, et al.
Journal of Medicinal Chemistry|September 26, 2019
Anti-biofilm Agents against <i>Pseudomonas aeruginosa</i>: A Structure-Activity Relationship Study of <i>C</i>-Glycosidic LecB InhibitorsRoman Sommer, Katharina Rox, Stefanie Wagner, et al.
American Journal of Infection Control|May 1, 2012
Perceived impact of the Medicare policy to adjust payment for health care-associated infectionsGrace M Lee, Christine W Hartmann, Denise Graham, et al.
Pageof 63

Showing results (561-570 of 626) with videos related to

Sort By:
Pageof 63
Angewandte Chemie (International Ed. in English)|November 11, 2021
Substrate-Inspired Fragment Merging and Growing Affords Efficacious LasB InhibitorsCansu Kaya, Isabell Walter, Samir Yahiaoui, et al.
International Journal of Molecular Medicine|July 13, 2000
Expression of genes involved with cell cycle control, cell growth and chromatin modification are altered in hepatoblastomasS G Gray, W Hartmann, T Eriksson, et al.
Journal of the American Chemical Society|September 21, 2012
Validation of PqsD as an anti-biofilm target in Pseudomonas aeruginosa by development of small-molecule inhibitorsMichael P Storz, Christine K Maurer, Christina Zimmer, et al.
Journal of Medicinal Chemistry|November 11, 2005
Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approachAndrea Cavalli, Alessandra Bisi, Carlo Bertucci, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 4, 2011
17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor developmentSandrine Marchais-Oberwinkler, Claudia Henn, Gabriele Möller, et al.
Klinische Padiatrie|December 1, 2007
Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastomaM A Grotzer, K von Hoff, A O von Bueren, et al.
Oncogene|March 6, 2007
SGNE1/7B2 is epigenetically altered and transcriptionally downregulated in human medulloblastomasA Waha, A Koch, W Hartmann, et al.
Bioorganic & Medicinal Chemistry|October 22, 2013
Trisubstituted and tetrasubstituted pyrazolines as a novel class of cell-growth inhibitors in tumor cells with wild type p53Mohammad Abdel-Halim, Adam B Keeton, Evrim Gurpinar, et al.
Journal of Medicinal Chemistry|September 26, 2019
Anti-biofilm Agents against <i>Pseudomonas aeruginosa</i>: A Structure-Activity Relationship Study of <i>C</i>-Glycosidic LecB InhibitorsRoman Sommer, Katharina Rox, Stefanie Wagner, et al.
American Journal of Infection Control|May 1, 2012
Perceived impact of the Medicare policy to adjust payment for health care-associated infectionsGrace M Lee, Christine W Hartmann, Denise Graham, et al.
Pageof 63